Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

450 transgender people join landmark health study in southeast asia

NCT ID NCT05454579

Knowledge-focused Sponsor: Institute of HIV Research and Innovation Foundation, Thailand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study followed 450 transgender people (300 HIV-negative and 150 living with HIV) from community health centers in Thailand, Vietnam, and the Philippines for 24 months. Researchers tracked new HIV infections, mental health, and social factors like stigma and violence using surveys and lab tests. The goal is to better understand the health needs of transgender individuals in the region.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal key factors affecting HIV and mental health in transgender communities, guiding better healthcare services.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

450 people

The number who actually took part.

Started

Dec 2022

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

* transgender woman or * transgender man

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Thai/Vietnamese/Filipino nationality * Aged ≥ 18 years old * Self-identify as a transgender woman or transgender man * Have signed consent form Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hepatitis C virus infection HIV infectious disease sexually transmitted disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HCV HIV STIS

Contacts and locations

Locations

  • Glink Clinics, Ho Chi Minh City (HCMC), Vietnam Glink Clinic HCMC1

    Ho Chi Minh City, Thuong Kiet Street, Vietnam

  • Institute of HIV Research and Innovation

    Pathum Wan, Bangkok, 10330, Thailand

  • Rainbow Sky Association of Thailand (RSAT)

    Bangkok, Bangkapi, 10240, Thailand

  • Tangerine Clinic, Institute of HIV Research and Innovation

    Pathum Wan, Bangkok, 10330, Thailand

  • Victoria by LoveYourself

    Pasay, Manila, Philippines

More trials for these conditions

Other studies related to the condition(s) this trial covers.